Trial Profile

A Randomized, Open-label, Parallel, Phase I/II Single-Dose Administration Trial of TLC599 in Subjects With Osteoarthritis of the Knee

Status: Completed

Phase of Trial: Phase I/II

Latest Information Update: 09 May 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Dexamethasone (Primary)
Indications Osteoarthritis
Focus Adverse reactions
Sponsors Taiwan Liposome Company

Most Recent Events

03 Sep 2018 According to a Taiwan Liposome Company media release, data from this study will be presented at the 20th Asia Pacific League of Associations for Rheumatology Congress (APLAR) on Sep 2018.
20 Aug 2018 Results presented in a Taiwan Liposome Company media release.
03 Jan 2017 According to a Taiwan Liposome Company media release, the observation period has lengthened to 24 weeks compared to the 12 week duration in this trial to determine the maximum duration of efficacy.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com